DNMT3A and chronic myelogenous leukemia, BCR-ABL1 positive: Its expression was evaluated in leukemia cells, in patients diagnosed with CLL, acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and chronic myelocytic leukemia (CML) and, in comparison to healthy controls, was downregulated and inversely correlated with DNA methyltransferase 3A (DNMT3A) [100].